Literature DB >> 28184080

The financial burden for the surgical management of osteoradionecrosis.

V Patel1, L Ormondroyd1, A Lyons2, M McGurk2.   

Abstract

Osteoradionecrosis (ORN) remains a difficult clinical problem. In large refractory cases surgery appears to be the only option but it does not guarantee a cure and is expensive. Cost analysis of 31 patients who had resection with or without reconstruction of their mandible was £892,357. The largest cost was in-patient stay, which accounted for 62% of the total. This article explores in detail the expenditure associated with major ORN surgery and its subsequent implications.

Entities:  

Mesh：

Year:  2017        PMID： 28184080     DOI： 10.1038/sj.bdj.2017.121

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


  9 in total

1.  Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy.

Authors:  Ken-Ichi Notani; Yutaka Yamazaki; Hideyuki Kitada; Noriyuki Sakakibara; Hiroshi Fukuda; Keiiti Omori; Motoyasu Nakamura
Journal:  Head Neck       Date:  2003-03       Impact factor: 3.147

Review 2.  Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review.

Authors:  S Nabil; N Samman
Journal:  Int J Oral Maxillofac Surg       Date:  2010-11-05       Impact factor: 2.789

3.  Use of pentoxifylline and tocopherol in the management of osteoradionecrosis.

Authors:  Vinod Patel; Yusuf Gadiwalla; Isabel Sassoon; Chris Sproat; Jerry Kwok; Mark McGurk
Journal:  Br J Oral Maxillofac Surg       Date:  2016-01-19       Impact factor: 1.651

4.  Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

Authors:  B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vaskovic; L Tadic
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

5.  Osteoradionecrosis: clinical experience and a proposal for classification.

Authors:  J B Epstein; F L Wong; P Stevenson-Moore
Journal:  J Oral Maxillofac Surg       Date:  1987-02       Impact factor: 1.895

6.  Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin.

Authors:  R E Marx; R P Johnson; S N Kline
Journal:  J Am Dent Assoc       Date:  1985-07       Impact factor: 3.634

7.  Osteoradionecrosis: a new concept of its pathophysiology.

Authors:  R E Marx
Journal:  J Oral Maxillofac Surg       Date:  1983-05       Impact factor: 1.895

8.  Prophylactic use of pentoxifylline and tocopherol in patients who require dental extractions after radiotherapy for cancer of the head and neck.

Authors:  Vinod Patel; Yusuf Gadiwalla; Isabel Sassoon; Chris Sproat; Jerry Kwok; Mark McGurk
Journal:  Br J Oral Maxillofac Surg       Date:  2016-03-11       Impact factor: 1.651

Review 9.  The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway.

Authors:  Sylvie Delanian; Jean-Louis Lefaix
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280
  9 in total
  2 in total

1.  MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.

Authors:  V Patel; J Mansi; S Ghosh; J Kwok; M Burke; D Reilly; N Nizarali; C Sproat; K Chia
Journal:  Br Dent J       Date:  2017-12-15       Impact factor: 1.626

2.  The role of exercise therapy in managing post-radiotherapy trismus in head and neck cancer.

Authors:  Yousef E Ezzat; Rayan M Sharka; Adel A Huzaimi; Khaled M Al-Zahrani; Hassan H Abed
Journal:  J Taibah Univ Med Sci       Date:  2020-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.